Article citationsMore>>

Cheng, D., Xu, J.H., Li, J.Y., et al. (2018) Butyrate Ameliorated-NLRC3 Protects the Intestinal Barrier in a GPR43-Dependent Manner. Experimental Cell Research, 368, 101-110.
https://doi.org/10.1016/j.yexcr.2018.04.018

has been cited by the following article:

• TITLE: Gut Microbiota and Metabolic Diseases

  AUTHORS: Qianqian Tang, Maogong Tang

  KEYWORDS: Gut Microbiota, Microbiota-Gut-Brain Axis, Metabolic Diseases, Interventions

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.11, November 18, 2022

  ABSTRACT: In this review, the characteristics of gut microbiota changes in 11 metabolic diseases, as well as the research progress on their interventions, are summarized. The gut microbiota contributes to metabolic diseases through intestinal mucosal dysfunction, chronic metabolic inflammatory response, gut brain axis imbalance, gene regulation, insulin resistance, and the action of its metabolites. The researches of cause effect relationship and mechanism are relatively few, need further study, expecting a breakthrough in the future to be a new path in the treatment of some metabolic diseases.